// App-Quantinova.ai

PB0436 : Plasma Levels of von Willebrand Factor and Future Risk of Incident Venous Thromboembolism

Researchers

Presenter

  • M.S. Edvardsen

Principal Investigators

  • K. Hindberg

  • V.M. Morelli

  • T. Ueland

  • P. Aukrust

  • S.K. Brkkan

  • L.H. Evensen

  • J.-B. Hansen

Medical Centers

  • The Arctic University of Norway, K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, Tromsø, Norway

  • Oslo University Hospital, Research Institute of Internal Medicine, Oslo, Norway

  • University Hospital of North Norway, Division of Mental Health and Addictions, Tromsø, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A